Abstract | PURPOSE: METHODS AND MATERIALS: Between 1974 and 1990, 164 patients were evaluated by members of Yale University School of Medicine departments of Dermatology and Therapeutic Radiology and treated with total skin electron beam therapy to a total dose of 3600 cGy. Patients who achieved a clinical complete response were offered doxorubicin/ cyclophosphamide chemotherapy, extracorporeal photopheresis, or no systemic adjuvant therapy. The effects of TNM stage, antecedent non- T-cell lymphoma dermatologic diagnoses, and systemic adjuvant therapies were analyzed for their impact on relapse-free and overall survival. RESULTS: CONCLUSION:
|
Authors | L D Wilson, D L Cooper, A L Goodrich, N D Friedman, A M Feldman, I M Braverman, B M Kacinski |
Journal | International journal of radiation oncology, biology, physics
(Int J Radiat Oncol Biol Phys)
Vol. 28
Issue 4
Pg. 829-37
(Mar 01 1994)
ISSN: 0360-3016 [Print] United States |
PMID | 8138435
(Publication Type: Journal Article)
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Chemotherapy, Adjuvant
- Humans
- Lymphoma, T-Cell, Cutaneous
(drug therapy, mortality, radiotherapy)
- Middle Aged
- PUVA Therapy
- Skin
(radiation effects)
- Survival Rate
|